Tuesday, December 01, 2009
European Regulators And Their Conflicts Of Interest
Ed Silverman over at Pharmalot writes about the conflicts of interest involving the pharmaceutical industry, the Irish Medicines Board, the Medicines and Healthcare products Regulatory Agency and the European Medicines Agency.
Findings, published in Social Science & Medicine, suggests there is reason for concern.
They found that the MHRA executive board since 2004 had five people who had industry backgrounds before joining the agency, one went on to an industry job after leaving and one participated in research funded by a drugmaker before joining the MHRA. In total, seven of 25, or 28 percent of MHRA personnel had a relationship with drugmakers.
“We found that of the 26 chairs of various Working Groups, Panels and Expert Advisory Groups 15 had personal interests, 12 had non-personal interests, 6 had both personal and non-personal interests and 10 had neither type of interest,” wrote the researchers. “Our review of the publicly available declarations of interests of the EMEA Management Board found that 25 percent of members declared interests in the pharmaceutical industry…
Read Ed's article HERE
TALES OF THE PAROXETINE TERATOGEN BY BOB FIDDAMAN
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
About the Author :
Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
Labels: bobfiddaman, Fiddaman, fiddaman blog, MHRA Correspondence, Paroxetine, Paxil, Seroxat, Seroxat Sufferers, Seroxat Sufferers Stand Up and be Counted, SSRis, THE EVIDENCE HOWEVER IS CLEAR